Navigation Links
Raptor Pharmaceuticals Provides Update of Product Programs
Date:9/13/2007

eins. The Company's preclinical programs target cancer, neurodegenerative disorders, infectious diseases and osteoporosis. HepTide(TM) utilizes engineered RAP-based peptides conjugated to drugs to target their delivery to the liver. In neurodegenerative diseases, engineered RAP peptides called NeuroTrans(TM) are currently undergoing evaluation at Stanford University in cell culture and preclinical models for their ability to enhance the transport of molecules from blood to brain. In osteoporosis, Raptor is testing the ability of WntTide, which are Mesd and engineered Mesd-based peptides and act through LRP5, a known determinant of bone density, to combat osteoporosis and increase bone density. In an effort to protect its novel approach, Raptor currently has five patent applications in review in the U.S., and countries in Europe and Asia, as well as two provisional patent applications licensed from Washington University. In addition, the Company has recently submitted two new provisional patent applications in the U.S., the first of which covers a new family of RAP peptides, with the second application to further support and expand the Company's coverage in specific disease indications. For additional information, please visit http://www.raptorpharma.com.

FORWARD LOOKING STATEMENTS

This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events, but are not limited to the ability of RAP to conjugate to drugs or to target the liver, the ability of RAP peptides to enhance the transport of molecules from blood to the brain, the ability of Mesd or Mesd-based peptides to combat osteoporosis and increase bone density. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause the Company's actual results to be materially different from
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 ... of the "Global Advanced Wound Care and ... - Size, Share, Global Trends, Company Profiles, Demand, ... 2013 - 2020" report to their offering. ... advanced wound care and closure market (types, applications, ...
(Date:8/20/2014)... ARBOR, Mich. and PHOENIX ... non-profit corporation established to bring cutting-edge next-generation sequencing ... to cancer patients, today announced a collaboration with ... capabilities to characterize patient tissue samples from clinical ... sensitive or resistant to TESARO,s TSR-011.  This may lead ...
(Date:8/20/2014)... LAKE WORTH, Fla. , Aug. 20, 2014  Glades ... Florida , is proud to announce its expansion into ... , which will feature an 8,000-square-foot office space and ... is currently accepting applications for 100 open positions for the ... located at 4560 Lantana Road will serve as the chain,s ...
Breaking Medicine Technology:Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2
... in Peer-Review Journal,Respiratory Medicine, SAN JOSE, Calif., ... Pulmonary Fibrosis (CPF) today announced a summary ... of the,largest databases of information on patients ... United States, was,published in Respiratory Medicine. The ...
... OBISPO, Calif.--(BUSINESS WIRE)--Mar 22, 2007 - FzioMed,Inc. announced ... on,novel, synthetic dermal fillers is being presented at ... March,22-24, 2007., In 2006, FzioMed launched Laresse Dermal ... the,company's patented polymer science. Laresse represents a completely,new ...
Cached Medicine Technology:Medical Journal Publishes First Large-Scale Survey Revealing,Experiences of IPF Patients 2Medical Journal Publishes First Large-Scale Survey Revealing,Experiences of IPF Patients 3Laresse Dermal Filler Research Presented at Anti-Aging World,Congress 2
(Date:8/20/2014)... 20, 2014 Botanica Day ... facial. Utilizing the new and popular stem cell ... fine lines and wrinkles and naturally repairs the ... highlighting the new service by offering clients a ... stem cell facial. , Pevonia® continues to be ...
(Date:8/20/2014)... -- Leaving the car at home and getting to work ... health, a new study indicates. Researchers looked at thousands ... percent of men and 72 percent of women drove to ... used public transit, and 14 percent of men and 17 ... to work weighed more and had higher levels of body ...
(Date:8/20/2014)... Chemically extracted acellular allogeneic nerve, from which ... have been removed, reduced postoperative immune rejection. ... neural substrates and base materials, such as ... can provide a good scaffold in the ... allogeneic nerve, similar to autologous nerve transplantation, ...
(Date:8/20/2014)... 20, 2014 Fresh from the cradle of ... sprung from the starting blocks. , Urbini, a new collection ... the Urbini Avi jogger to its lineup. , ... with a look inspired by the latest racing styles and ... , This versatile jogger offers a swift, smooth ride on ...
(Date:8/20/2014)... August 20, 2014 The National ... five-year, $1.24 million Science Education Partnership Award (SEPA) ... support NAHN’s collaborative project with the Hispanic Communications ... Careers. , This collaborative NIH R25 program has ... and linguistic diversity among health professionals by recruiting ...
Breaking Medicine News(10 mins):Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3Health News:Want to Stay Slim? Leave the Car at Home 2Health News:Urbini Breezes Through Summer with New Jogging Stroller 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3
... Irvine scientists will receive grants totaling $9.35 million to ... disease and traumatic brain injury. The grants from ... Oct. 21, to Dr. Henry Klassen, Leslie M. Thompson, ... the Sue and Bill Gross Stem Cell Research Center ...
... interdisciplinary approach to drug abuse and addiction research, The ... has been renewed as a "Center of Excellence" by ... National Institutes of Health. The designation comes with ... to further studies led by researchers and clinicians in ...
... University of California, San Diego School of Medicine indicates that ... plans that include parents and child, while at the same ... , The results were published today in the advanced online ... Boutelle, PhD, associate professor of pediatrics and psychiatry at UC ...
... (HealthDay News) -- A new study suggests that in women ... tissue in addition to a cancerous breast tumor is enough ... about how much of a "free margin" around a tumor ... the November issue of IJCP, the International Journal of ...
... A new research study conducted by Boston University ... significantly improve biennial mammography screening rates among inner city ... Journal of General Internal Medicine , indicate the importance ... patient populations. Breast cancer is the second ...
... , THURSDAY, Oct. 21 (HealthDay News) -- Over the ... in the United States will be 10 times greater ... that could affect cancer patients, access to treatment, according ... the number of patients requiring radiation therapy will increase ...
Cached Medicine News:Health News:UCI stem cell researchers to receive $9.35 million in state funding 2Health News:UCI stem cell researchers to receive $9.35 million in state funding 3Health News:UTHealth receives $11 million NIDA grant 2Health News:Parent-only treatment may be equally effective for children who are obese 2Health News:New Finding Suggests Safe Surgical Margins When Removing Breast Cancers 2Health News:BUSM study shows patient navigations improve mammography rates in minority women 2Health News:Demand for Radiation Therapy Predicted to Exceed Supply 2
The focus of HandEchart Professional is to offer a practical and basic electronic patient record keeping system that anyone can learn in minutes....
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
A handy, quick reference for physicians, nurses, and other health care providers treating cancer patients....
A handy quick-reference tool for busy residents and clinicians with key facts and points essential for day-to-day patient care....
Medicine Products: